Conexeu Sciences issues 4.34M shares on warrant exercise, raises ~$1.96M; amends bylaws to increase quorum

Conexeu Sciences Inc.

Issued 4,342,648 common shares upon exercise of warrants for aggregate gross proceeds of ~$1,963,967.
Issued 4,342,648 Incentive Warrants exercisable at $2.30/share for 36 months as inducement.
Bylaws amended to increase stockholder meeting quorum from 5% to 33.3% to comply with Nasdaq Rule 5620(c).
Also issued 11,175 shares at $4.00 to a director for compensation on May 14, 2026.
Proceeds for working capital; 827,005 Program Warrants remain outstanding.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Conexeu Sciences Inc.: Increased quorum requirement for stockholder meetings from one-twentieth to one-third of outstanding shares (effective 2026-05-11).

Change: bylaw amendment
Effective: 2026-05-11

Exact text from the filing

On May 11, 2026, the Board of Directors of the Company approved an amendment to the bylaws (the " Bylaws ") of the Company in order to increase the quorum requirement for meetings of stockholders from one-twentieth (1/20) of the outstanding shares of the Company entitled to vote at any such meeting, represented in person or by proxy, to one-third (331⁄3%) of the outstanding shares of the Company entitled to vote, represented in person or by proxy.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Conexeu Sciences Inc. filing history →

Source: SEC EDGAR

accession 0001062993-26-002703

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.